However , with the availability of marketed products for a number of the most frequently targeted orphan indications , competition in these areas is set to grow . * Gain insight into the challenges companies face when developing and commercializing orphan drugs . * Examine which are the most popular orphan indications , and the most dominant orphan drug players in the market . * Identify strategies to maximize the commercial opportunities of orphan drugs through both revenue expansion and protection .